Literature DB >> 28731193

Promotion of glycolysis by HOTAIR through GLUT1 upregulation via mTOR signaling.

Shibo Wei1, Qing Fan2, Liang Yang2, Xiaodong Zhang2, Yingbo Ma2, Zhihong Zong3, Xiangdong Hua4, Dongming Su5, Hongzhi Sun6, Hangyu Li2, Zhen Liu1.   

Abstract

The long non-coding RNA HOX transcript antisense RNA (HOTAIR) plays a key role in the progression of various carcinomas. However, whether or not HOTAIR influences glucose metabolism and the specific underlying mechanism in hepatocellular carcinoma (HCC) cells remain unclear. In the present study, we found markedly increased HOTAIR expression in 84 HCC tissues and demonstrated that HOTAIR overexpression promoted cell proliferation using Cell Counting Kit-8. The effect on glucose metabolism regulated by HOTAIR in HCC cells was determined by detecting lactate and glucose levels: HOTAIR promoted glycolysis by upregulating glucose transporter isoform 1 (GLUT1) and activating mammalian target of rapamycin (mTOR) signaling, whereas knockdown of HOTAIR suppressed this effect. Our research reveals a novel relationship between HOTAIR and glucose metabolism in HCC cells, and it may be a therapeutic target for diagnosing and treating HCC.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28731193     DOI: 10.3892/or.2017.5840

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  34 in total

Review 1.  Long non-coding RNA-based glycolysis-targeted cancer therapy: feasibility, progression and limitations.

Authors:  Xiaman Wang; Ying Shen; Rui Liu; Aili He
Journal:  Mol Biol Rep       Date:  2021-03-11       Impact factor: 2.316

Review 2.  Long non-coding RNAs involved in cancer metabolic reprogramming.

Authors:  Hui Liu; Junyun Luo; Siyu Luan; Chongsheng He; Zhaoyong Li
Journal:  Cell Mol Life Sci       Date:  2018-10-19       Impact factor: 9.261

Review 3.  Regulation of mTOR signaling by long non-coding RNA.

Authors:  Karam Aboudehen
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-11-18       Impact factor: 4.490

4.  LncRNA NBR2 aggravates hepatoblastoma cell malignancy and promotes cell proliferation under glucose starvation through the miR-22/TCF7 axis.

Authors:  Chengguang Zhu; Xiangling He; Keke Chen; Zhijun Huang; Anqi Yao; Xin Tian; Yalan You; Minhui Zeng
Journal:  Cell Cycle       Date:  2021-03-02       Impact factor: 4.534

Review 5.  Towards decoding the coupled decision-making of metabolism and epithelial-to-mesenchymal transition in cancer.

Authors:  Dongya Jia; Jun Hyoung Park; Harsimran Kaur; Kwang Hwa Jung; Sukjin Yang; Shubham Tripathi; Madeline Galbraith; Youyuan Deng; Mohit Kumar Jolly; Benny Abraham Kaipparettu; José N Onuchic; Herbert Levine
Journal:  Br J Cancer       Date:  2021-04-15       Impact factor: 9.075

Review 6.  Research advances on epigenetics and cancer metabolism.

Authors:  Hengyi Han; Fan Feng; Haitao Li
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-02-25

7.  lncRNA GAS6-AS1 inhibits progression and glucose metabolism reprogramming in LUAD via repressing E2F1-mediated transcription of GLUT1.

Authors:  Jing Luo; Huishan Wang; Li Wang; Gaoming Wang; Yu Yao; Kai Xie; Xiaokun Li; Lin Xu; Yi Shen; Binhui Ren
Journal:  Mol Ther Nucleic Acids       Date:  2021-05-01       Impact factor: 8.886

Review 8.  Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway.

Authors:  Mengnan Guo; Ning Li; Jianxia Zheng; Wei Wang; Yan Wu; Xu Han; Jiapei Guo; Weixi Chen; Zekun Bai; Wen Bai; Jinghua Wu
Journal:  Can J Gastroenterol Hepatol       Date:  2021-05-25

Review 9.  Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer.

Authors:  Alba Loras; Cristina Segovia; José Luis Ruiz-Cerdá
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

10.  Targeting Long Non-Coding RNAs in Hepatocellular Carcinoma: Progress and Prospects.

Authors:  Xinrong Lin; Xiaosong Xiang; Bing Feng; Hao Zhou; Ting Wang; Xiaoyuan Chu; Rui Wang
Journal:  Front Oncol       Date:  2021-06-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.